DE602006014106D1 - Verfahren zur diagnose von prostatakrebs - Google Patents

Verfahren zur diagnose von prostatakrebs

Info

Publication number
DE602006014106D1
DE602006014106D1 DE602006014106T DE602006014106T DE602006014106D1 DE 602006014106 D1 DE602006014106 D1 DE 602006014106D1 DE 602006014106 T DE602006014106 T DE 602006014106T DE 602006014106 T DE602006014106 T DE 602006014106T DE 602006014106 D1 DE602006014106 D1 DE 602006014106D1
Authority
DE
Germany
Prior art keywords
diagnosis
prostate cancer
prostate
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006014106T
Other languages
English (en)
Inventor
Kazutake Tsujikawa
Hiroshi Yamamoto
Noboru Konishi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Osaka University NUC
Link Genomics Inc
Original Assignee
Osaka University NUC
Link Genomics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Osaka University NUC, Link Genomics Inc filed Critical Osaka University NUC
Publication of DE602006014106D1 publication Critical patent/DE602006014106D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3069—Reproductive system, e.g. ovaria, uterus, testes, prostate
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57434—Specifically defined cancers of prostate

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Rehabilitation Therapy (AREA)
  • Hospice & Palliative Care (AREA)
  • Rheumatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE602006014106T 2005-03-14 2006-03-14 Verfahren zur diagnose von prostatakrebs Active DE602006014106D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2005071387 2005-03-14
JP2005241414 2005-08-23
PCT/JP2006/305480 WO2006098464A1 (ja) 2005-03-14 2006-03-14 前立腺がんの診断方法

Publications (1)

Publication Number Publication Date
DE602006014106D1 true DE602006014106D1 (de) 2010-06-17

Family

ID=36991808

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006014106T Active DE602006014106D1 (de) 2005-03-14 2006-03-14 Verfahren zur diagnose von prostatakrebs

Country Status (5)

Country Link
US (1) US20090130662A1 (de)
EP (1) EP1862804B1 (de)
JP (1) JPWO2006098464A1 (de)
DE (1) DE602006014106D1 (de)
WO (1) WO2006098464A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5549907B2 (ja) * 2009-06-17 2014-07-16 国立大学法人大阪大学 膵臓癌の予防・治療剤及びそのスクリーニング方法、並びに診断剤
CN102236020A (zh) * 2010-04-20 2011-11-09 上海新波生物技术有限公司 丙型肝炎病毒抗体时间分辨免疫荧光分析法及试剂盒
CN102236012A (zh) * 2010-04-21 2011-11-09 深圳出入境检验检疫局食品检验检疫技术中心 检测氯丙嗪的时间分辨荧光免疫分析试剂盒及其检测方法
CN101806802B (zh) * 2010-04-29 2013-06-26 华中科技大学 基于荧光共振能量转移的均相时间分辨荧光多组分同时检测方法
CN102539750A (zh) * 2011-11-25 2012-07-04 佛山市中南农业科技有限公司 氯丙嗪残留的时间分辨免疫分析检测试剂盒及其检测方法
JP5854390B2 (ja) 2012-03-01 2016-02-09 学校法人兵庫医科大学 新規ベンズイミダゾール誘導体及びその用途
EP2957911A4 (de) * 2013-02-15 2016-08-31 Kureha Corp Indoxyl-sulfat-messverfahren
CN104062429B (zh) * 2014-06-12 2016-02-17 美艾利尔（上海）诊断产品有限公司 一种检测鼠源抗体的时间分辨免疫荧光试剂盒及其制备方法和应用
GB201513921D0 (en) 2015-08-05 2015-09-23 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
CN110412272B (zh) * 2019-06-26 2020-06-19 四川大学华西医院 Alkbh3自身抗体检测试剂在制备肺癌筛查试剂盒中的用途
CN115950969B (zh) * 2022-11-08 2023-09-01 中国计量科学研究院 一种血清中游离前列腺特异抗原的定值方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2915082A (en) 1956-12-03 1959-12-01 Evart V Shaw Automobile beverage container assembly
CA1219824A (en) 1981-04-17 1987-03-31 David C. Ward Modified nucleotides and methods of preparing and using same
EP0128018B1 (de) 1983-05-31 1992-07-15 Orgenics Ltd. Molekulare genetische Sonde und Verfahren zu ihrer Herstellung, Testmethode und Satz in denen diese molekulare genetische Sonde gebraucht wird
DE3431536A1 (de) 1984-08-28 1986-03-13 Boehringer Mannheim Gmbh, 6800 Mannheim Derivatisierte nucleinsaeure-sequenz, verfahren zu deren herstellung sowie deren verwendung zum nachweis von nucleinsaeuren
DK171161B1 (da) 1985-03-28 1996-07-08 Hoffmann La Roche Fremgangsmåde til påvisning af forekomst eller fravær af mindst én specifik nukleinsyresekvens i en prøve eller til skelnen mellem to forskellige nukleinsyresekvenser i denne prøve
DE3813278A1 (de) 1988-01-12 1989-07-20 Boehringer Mannheim Gmbh Verfahren zum nachweis von nukleinsaeuren
JPH0373280A (ja) 1989-03-20 1991-03-28 Kunii Nakada タガネ及びその装着用ホルダー
ES2108048T3 (es) 1990-08-29 1997-12-16 Genpharm Int Produccion y utilizacion de animales inferiores transgenicos capaces de producir anticuerpos heterologos.
CA2161351C (en) 1993-04-26 2010-12-21 Nils Lonberg Transgenic non-human animals capable of producing heterologous antibodies
AU2003263296A1 (en) * 2002-08-30 2004-03-19 Imperial Cancer Research Technology Dna repair enzymes
CN1930292B (zh) 2004-03-15 2014-04-02 独立行政法人科学技术振兴机构 硼酸抗性给予蛋白质及其基因

Also Published As

Publication number Publication date
US20090130662A1 (en) 2009-05-21
EP1862804A1 (de) 2007-12-05
WO2006098464A1 (ja) 2006-09-21
EP1862804A4 (de) 2008-06-18
EP1862804B1 (de) 2010-05-05
JPWO2006098464A1 (ja) 2008-08-28

Similar Documents

Publication Publication Date Title
DE602006014106D1 (de) Verfahren zur diagnose von prostatakrebs
DE602006019133D1 (de) Verfahren zur nicht-invasiven glucosemessung
ATE493511T1 (de) Oligonukleotide zur brustkrebsdiagnose
ATE442786T1 (de) Verfahren zur anregung der darmflora
ATE408604T1 (de) Verfahren zur herstellung von 1-alkyl-3- phenyluracilen
ATE455105T1 (de) Verfahren zur herstellung von difluormethylpyrazolylcarboxylaten
DE602005012489D1 (de) Verfahren zur Abwasserbehandlung
DE112006000054A5 (de) Verfahren zur Diagnose eines Abgasnachbehandlungssystems
AT505105A3 (de) Verfahren zur beurteilung der fahrbarkeit von fahrzeugen
DE502005010287D1 (de) Verfahren zur hydrocyanierung
ATE480531T1 (de) Verfahren zur herstellung von benzopyran-2- olderivaten
DE602006015892D1 (de) Verfahren zur Beschichtung von metallen
DE602006014679D1 (de) Verfahren zur bestimmung der eisenkonzentration
DE602006020089D1 (de) Verfahren zur CVI
ATE555214T1 (de) Verfahren zur diagnose proliferativer erkrankungen durch detektion von genmethylierung
ATE444303T1 (de) Verfahren zur herstellung von ferrisuccinylcasein
DE602006013109D1 (de) Markerprotein zur verwendung bei der diagnose von bauchspeicheldrüsenkrebs
DE102007044925B8 (de) Verfahren zur Stillstands-/Bewegungsbestimmung von Fahrzeugen
ATE525481T1 (de) Verfahren zur diagnose thromboembolischer erkrankungen und koronarer herzerkrankungen
DE602006008119D1 (de) Verfahren zur UWB-Modulation von M-Stufigen Sequenzen
DE502006006353D1 (de) Verfahren zur hydrosilylierung
ATE506446T1 (de) Verfahren zur enantioselektiven enzymatischen reduktion von ketoverbindungen
DE60333195D1 (de) Verfahren zur diagnose des myokardinfarktrisikos
DE502005002018D1 (de) Verfahren zur Formung von Signalspektren
DE602005003444D1 (de) Verfahren zur kostengünstigen Detektion von Ultrabreitbandpulsfolgen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
R082 Change of representative

Ref document number: 1862804

Country of ref document: EP

Representative=s name: SPLANEMANN PATENT- UND RECHTSANWAELTE PARTNERSCHAF